Skip to main content
Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient.
Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.
Disparities in household material hardship, financial toxicity, and income loss in pediatric cancer.
Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).
EML4::ALK fusions in complex lymphatic malformations.
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
How I approach B-lymphoblastic lymphoma in children.
Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.